Gene · 6683
Papers1,637
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,637
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reticulon-1 synthesis controls outgrowth and microtubule dynamics in injured cortical axons. | Life Sci Alliance | 2026 | 41545196 | PubTator, text mining | PubMed |
| Serendipitous Symptom Control: Allopurinol for Spasticity in a Case of SPG4-Linked Hereditary Spastic Paraplegia-A Case Report. | Clin Case Rep | 2026 | 41541044 | PubTator, text mining | PubMed |
| Hereditary spastic paraplegia: from decades of therapy to future innovations. | Ther Adv Neurol Disord | 2026 | 41537160 | PubTator, text mining | PubMed |
| Computational perspectives on tubulin E-hook structure and mechanisms. | Biophys Rep (N Y) | 2026 | 41519300 | PubTator, text mining | PubMed |
| Subclinical involvement of central nervous system structures other than motor or sensory tracts in SPG3A and SPG4 patients. | BMC Neurol | 2026 | 41507865 | PubTator, text mining | PubMed |
| Fampridine in Hereditary Spastic Paraplegia Type 4 With SPAST Variant c.683-2A>C: A Case Report. | Am J Case Rep | 2026 | 41496376 | PubTator, text mining | PubMed |
| Systematic Review on Genetic Variants in Children With Cerebral Palsy. | Acta Paediatr | 2026 | 41442323 | PubTator, text mining | PubMed |
| Comprehensive Characterization of Spastic Paraplegia in Korean Patients: A Single-Center Experience over Two Decades. | Yonsei Med J | 2026 | 41431411 | PubTator, text mining | PubMed |
| Reversing Autophagy Inhibition Ameliorates Neurodegeneration in Hereditary Spastic Paraplegia Caused by a Degradation-Resistant SPAST Mutation. | Mov Disord | 2026 | 41403389 | PubTator, text mining | PubMed |
| Novel and rare variants in amyotrophic lateral sclerosis genes identified in Malaysian patients. | Amyotroph Lateral Scler Frontotemporal Degener | 2026 | 41359433 | PubTator, text mining | PubMed |
| Spectrum of Movement Disorders in Early-Onset Hereditary Spastic Paraplegia: A Study of 428 Cases. | Mov Disord | 2026 | 41328529 | PubTator, text mining | PubMed |
| Intracerebroventricular SPAST-AAV9 gene therapy prevents manifestation of symptoms in a mouse model of SPG4 hereditary spastic paraplegia. | Mol Ther | 2026 | 41311060 | PubTator, text mining | PubMed |
| The Genetic Landscape of Hereditary Spastic Paraplegia in Greece. | Clin Genet | 2026 | 41277402 | PubTator, text mining | PubMed |
| Expanding Hereditary Spastic Paraplegias Limits: Biallelic SPAST Variants in Cerebral Palsy Mimics. | Ann Clin Transl Neurol | 2026 | 41000004 | PubTator, text mining | PubMed |
| Serum NfL, but not GFAP, differentiates primary lateral sclerosis from adrenomyeloneuropathy and hereditary spastic paraplegia type 4. | Amyotroph Lateral Scler Frontotemporal Degener | 2026 | 40961460 | PubTator, text mining | PubMed |
| Structure, function and assembly of nuclear pore complexes. | Nat Rev Mol Cell Biol | 2026 | 40926106 | PubTator, text mining | PubMed |
| The Cullin3-Ring E3 ubiquitin ligase complex and USP14 regulate spastin-mediated microtubule severing and promotion of neurite outgrowth. | Neural Regen Res | 2026 | 40587243 | PubTator, text mining | PubMed |
| DeSUMOylation of Spastin Enhances AMPA Receptor Recycling and Synaptic Plasticity via IST1-Dependent Endosomal Sorting. | Mol Neurobiol | 2025 | 41296224 | PubTator, text mining | PubMed |
| Limited sensitivity of somatosensory evoked potentials as disease monitoring biomarkers in hereditary spastic paraplegias. | PLoS One | 2025 | 41218046 | PubTator, text mining | PubMed |
| Globalizing newborn screening: bridging gaps in genetic diagnosis and treatment. | Front Pediatr | 2025 | 41181182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6683/papers?page=3